INVICTUS ACREAGE PHARMS MAKES FIRST PROVINCIAL BULK SHIPMENT OF RECREATIONAL CANNABIS ON SCHEDULE
September 07 2018 - 12:28PM
InvestorsHub NewsWire
INVICTUS ACREAGE PHARMS MAKES FIRST PROVINCIAL BULK
SHIPMENT OF RECREATIONAL CANNABIS ON SCHEDULE
Vancouver, BC -- September
7, 2018 -- InvestorsHub NewsWire -- INVICTUS
MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)
is pleased to
have completed its first shipment of recreational cannabis under
Provincial supply agreement on schedule, ensuring quality product
for opening day on October 17, 2018. Staff have been
working 24 hours per day, seven days
a week to package product in order to meet this
ambitious deadline.
"The cannabis
industry is moving rapidly to ramp-up production and deliver
a steady supply
of product to the recreational market in Canada," said Dan
Kriznic, Chairman and CEO of Invictus. "I am
extremely proud of our team for
achieving
this significant milestone."
To date,
Invictus'
wholly-owned
subsidiary Acreage Pharms has secured
provincial supply agreements for the upcoming adult recreational
markets in both British Columbia and
Alberta, while actively pursuing
supply agreements in other
provinces. Invictus products will be sold under
four lifestyle-inspired cannabis
brands for recreational users: Dukes, Zooey, Sterling & Hunt,
and Sinister.
For more
information, please visit www.invictus-md.com.
On Behalf of the
Board,
Dan
Kriznic
Chairman
and
CEO
Jessica
Martin
Vice
President, Public Relations and
Regulatory Affairs
(604) 537-8676
About Invictus
Invictus is a
global cannabis company offering a selection of products under a
wide range of lifestyle brands. Our integrated sales approach is
defined by five pillars of distribution including medical,
adult-use, international, Licensed
Producer to Licensed Producer and retail stores.
Invictus has
partnered with business leaders to convey our corporate vision,
including KISS music legend and business mogul Gene Simmons as our
Chief Evangelist Officer, and global branding agency Authentic
Brands Group. Invictus is expanding its cultivation footprint, with
two cannabis production facilities fully licensed under ACMPR in
Canada and a third awaiting approval, featuring 100,000 square feet
of available grow space today with 200,000 expected by
January
2019 and
1 million by end of 2019. The Company will earmark 50 per cent of
production to the medical and recreational markets, respectively.
To ensure consistency in quality and supply, Invictus maintains all
aspects of the growing process through its subsidiary, Future
Harvest Development Ltd., a high-quality Fertilizer and Nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over 69 Health
Canada approved
strains and a multifaceted distribution
strategy including
medical, recreational,
international and retail. For more information visit
www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including the potential
production capacity of Invictus, are forward-looking statements and
contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events or results "may", "could", "should", "would" or
"occur". Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that Invictus will be successful in reaching its
potential production capacity, its production facilities will be
completed as anticipated, regulatory approval will be granted as
anticipated, Invictus will reach full production capacity on the
timeline anticipated by the Company, and no unforeseen construction
delays will be experienced. These forward-looking statements are
subject to known and unknown risks, uncertainties and other factors
that may cause the actual results, level of activity, performance
or achievements of the Company to be materially different from
those expressed or implied by such forward-looking statements or
forward-looking information. Important factors that may cause
actual results to vary, include, without limitation, Invictus will
not be successful in reaching its potential production capacity,
its production facilities will not be completed as anticipated, and
licenses or approvals being granted on terms or timelines that are
materially worse than expected by the Company. Although management
of the Company has attempted to identify important factors that
could cause actual results to differ materially from those
contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Sep 2023 to Sep 2024